Bobak R. Azamian
Co-Founder, President, CEO & ChairmanDr. Bobak R. Azamian, also known as Bobby, MD, Ph.D, DPhil, is Director of Vibrato Medical, Inc. Dr. Azamian is Co-Founder of Tarsus Pharmaceuticals, Inc in November 2016 and serves as its President since November 2016. He serves as Chief Executive Officer at Tarsus Pharmaceuticals, Inc. since September 2018 and serves as its Director since December 2016. He serves as Chairman of Tarsus Pharmaceuticals, Inc. since December 02, 2022. Dr. Azamian co-founded and served as Chief Executive Officer, President and Chief Medical Officer of Metavention, Inc., a company focused on treatment of diabetes and other metabolic diseases. Since September 2016, Dr. Azamian had also served as co-Founder, Co-Chairman and Chief Executive Officer of Vibrato Medical, Inc., a medical device company developing wearable treatments for peripheral arterial disease until January 2021. Dr. Azamian previously served as an Entrepreneur in Residence at Versant Ventures from 2011 to 2013 and as a consultant and Senior Associate at Third Rock Ventures from 2007 to 2011, both venture capital firms focused on investing in early-stage healthcare companies and earlier served as a consultant at Amgen. Dr. Azamian also actively provided support and guidance for these companies in early operational roles and as a Board observer. He also completed residency in internal medicine and served as an attending hospitalist at Brigham and Women’s Hospital from 2006 to 2011. Dr. Azamian is also a Board Observer of Inceptus Medical, Intersection Medical, MD Start and Sequent Medical. Additionally, he is a Director of OCTANe and serves on the Leadership Council of the Edwards Lifesciences Center for Advanced Cardiovascular Technology at UC Irvine. Dr. Azamian holds an D.Phil. in Chemistry from Oxford University as a Rhodes Scholar; Doctor of Medicine from Harvard Medical School and a B.A. in BioPhysics from Rice University.
Positions
- Company NameTarsus Pharmaceuticals, Inc.Stock CodeTARSPositionCo-Founder, President, CEO & ChairmanColleagues
- JSJeffrey S. FarrowCFO & Chief Strategy Officer
- SNSeshadri NeervannanChief Operating Officer
- BWBryan WahlGeneral Counsel & Corporate Secretary
- DNDavid NakasoneHead of Investor Relations
- WJWilliam J. LinkIndependent Director
- WLWendy L. YarnoLead Independent Director
- SWScott William MorrisonIndependent Director
- BCBhaskar ChaudhuriIndependent Director
